Perifosine and Sutent
This page is for information related to Perifosine and Sutent, one of the combination drug trials under Clinical Trial Drugs. Feel free to add your own experiences with the trial in the comments section or any other links to useful resources.
[edit] Basic Information
Manufacturer: Perifosine is under development by KERYX Biopharmaceuticals. Sunitinib (Sutent) is an approved drug manufactured by Pfizer.
Molecular Targets: AKT pathway for perifosine (KIT, PDGFRA, and VEGF for Sutent)
Trial: Phase II trial of this drug combination is currently underway - follow this link
GIST Support International website page: link here
GIST Support Wiki